Surgical management of giant fibroelastoma of the aortic valve with repair through valve sparing technique  by Di Summa, Michele & Iezzi, Federica
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Background:  Fibroelastomas  account  for less  than  10%  of all  cardiac  tumors,  representing  the most  com-
mon  valvular  and  the  second  most  common  cardiac  benign  tumor,  following  myxomas.
Fibroelastomas  are  histologically  benign,  but they  can  result  in  life-threatening  complications  such  as
stroke,  acute  valvular  dysfunction,  embolism,  ventricular  ﬁbrillation,  and sudden  death.
Methods: A  valve-sparing  technique  with  simple  shave  excision  of  the tumor  was  undertaken  with  suc-eywords:
ortic ﬁbroelastoma
ardiac tumor
alve-sparing procedure
cess.
Results:  Surgical  resection  should  be offered  to all  patients  who  have  symptoms  and  to asymptomatic
patients  who  have  pedunculated  lesions  or tumors  larger  than  1 cm  in diameter.  Valve-sparing  excision
produces  good  long-term  results  in  most  instances.
Conclusion: We report  our  surgical  experience  of  a giant  ﬁbroelastoma  in  the  aortic  valve.
<Learning objective:  Medical  and  surgical  management  of giant  ﬁbroelastoma  of aortic  valve.>
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Cardiac ﬁbroelastomas are the most common benign neoplasms
f the cardiac valvular structures.
Fibroelastoma is often attached to valve leaﬂets, most often
o the aortic valve, and less frequently to the tricuspid, mitral,
nd pulmonary valves. Although most cases of ﬁbroelastoma are
ncidental ﬁndings because they are asymptomatic, some show a
trong propensity toward embolization, causing angina, myocar-
ial infarction, transient ischemic attack, stroke, or sudden death
hen the tumor is in the left side of the heart.
Here, we report our treatment of a giant aortic valve ﬁbroelas-
oma.
ase report
An 18-year-old man  was referred for the evaluation of fatigue,
hest pain, and syncope.
His  fatigue initially consisted of effort intolerance. He did not
nitially seek medical attention for his fatigue and syncope. His
hest discomfort was described as a squeezing sensation that was
ubsternal in location without radiation to any other position. His
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syncope was always preceded by substernal chest pressure, dizzi-
ness, and breathlessness.
A  transesophageal echocardiogram demonstrated a 70 mm
mobile mass adherent to the left coronary cusp of the aortic valve,
a sign of left ventricular outﬂow tract obstruction.
The mass was a pedunculated, echo dense, stipple in tex-
ture structure, with well-demarcated borders, features typical of
a ﬁbroelastoma.
The cardiac ﬁbroelastoma was  responsible for left ventricular
outﬂow tract obstruction and valvular dysfunction.
The patient underwent surgical excision of the mass.
Preparation for operation, median sternotomy, cardiopul-
monary bypass, and myocardial management were performed. The
tumor was  found to have a wide attachment to the surface of the
ventricular aspect of the left coronary cusp extending from the
aortic annulus to the edge of the cusp.
The tumor had well-demarcated borders and homogenous tex-
ture in appearance (Fig. 1).
The size of the tumor was  about 70 mm × 20 mm (Fig. 2).
The tumor in the chamber had independent mobility on valvular
endocardium surface and had an identiﬁable stalk.
Aortic valve insufﬁciency was the result of late diagnosis and
mechanical trauma of the valve due to the mass.
A valve-sparing technique with simple shave excision of thetumor was undertaken with particular care in avoiding emboliza-
tion and ensuring that no remnants from fragmentation of the
tumor were left behind both locally on the cusp and in the vicinity
of ascending aorta and left ventricle
vier Ltd. All rights reserved.
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Fig. 1. Giant aortic ﬁbroelastoma.
t
l
[
[
[
of  cardiac papillary ﬁbroelastoma: a single center experience with eighty-eightFig. 2. Fibroelastoma after surgical excision.Aortic valve competence was conﬁrmed intraoperatively with
ransesophageal echocardiographic approach.
Pathological examination of the excised mass showed a frond-
ike villous surface with a hyalinized myxoid core, delineated by a
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layer of endothelial cells-ﬁndings consistent with a classic ﬁbroe-
lastoma.
The patient recovered without any complications and remained
free of symptoms.
No  mass was  detected by echocardiography in the patient dur-
ing the 6 month follow-up period.
Discussion
Cardiac ﬁbroelastomas have a high propensity to affect the aor-
tic valve, the left ventricular outﬂow tract, and the anterior mitral
leaﬂet.
Fibroelastomas arising from semilunar valves are located with
equal frequencies on the ventricular and arterial sides of the valves.
In addition, non-valvular origin was observed in approximately 16%
of cases that included left and right ventricular septal and mural
endocardial surfaces, atrial endocardium, papillary muscles, chor-
dae tendinae, or intima of the right coronary ostium [1].
The  majority of patients are asymptomatic and the tumors are
most often incidentally diagnosed. Fibroelastomas have the poten-
tial to lead to life-threatening complications from embolization
of fragments into the coronary arteries, systemic circulation, pul-
monary circulation, and left ventricle outﬂow tract obstruction [2].
Symptomatic patients should be referred for curative surgical
excision of the tumor. Asymptomatic patients with large (>1 cm)
mobile masses especially left sided, should also be considered can-
didates for curative surgical excision due to the increased risk of
cardiovascular complications from embolization and sudden car-
diac death. Asymptomatic patients with small left-sided nonmobile
lesions are being closely followed up with echocardiography until
symptoms develop or tumors enlarge and become mobile [3].
Aortic  valve should be preserved preferably. In case, if there
is resultant valve defect, it should be repaired, otherwise a valve
replacement is warranted. The surgical resection is curative, safe,
and well tolerated [4].
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